NeuroPace Q2 2026 slides: 21% RNS growth, $55B+ market opportunity
3 sources
·6h ago
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation.
In the news · 1
More in Healthcare